Use of 6-[18F]-fluorodopamine positron emission tomography (PET) as first-line investigation for the diagnosis and localization of non-metastatic and metastatic phaeochromocytoma (PHEO). [electronic resource]
- Clinical endocrinology Jul 2009
- 11-7 p. digital
Publication Type: Clinical Trial; Journal Article; Research Support, N.I.H., Intramural